These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [The conduct of anticoagulant therapy]. Larcan A; Gilgenkrantz JM; Streiff F; Calamai N Presse Med (1893); 1968 Feb; 76(10):457-9. PubMed ID: 5639856 [No Abstract] [Full Text] [Related]
27. [State of the blood coagulation system under the experimental action of the anticoagulant bephedon hyperbaric oxygenation and their combination]. Reznikov KM; Trukhacheva LI; Ekimov VA Probl Gematol Pereliv Krovi; 1981 Nov; 26(11):34-7. PubMed ID: 7323040 [No Abstract] [Full Text] [Related]
29. [Behavior of prothrombin factors during treatment with anticoagulants of the coumarin & indandione series]. CROLLE G; RAVERA M Minerva Cardioangiol; 1958 Jun; 6(6):356-61. PubMed ID: 13577460 [No Abstract] [Full Text] [Related]
30. THE ANTICOAGULANT ACTION OF 2,2'-ARYLENE-BIS-INDANDIONE-1,3. GUMINSKA M; ECKSTEIN M; STACHURSKA B Farmaco Sci; 1964 Aug; 19():653-60. PubMed ID: 14180152 [No Abstract] [Full Text] [Related]
31. Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration. de Vries J; Verboom CN; Groot EJ; Nauta WT; Wattel E Eur J Drug Metab Pharmacokinet; 1979; 4(4):225-9. PubMed ID: 535602 [TBL] [Abstract][Full Text] [Related]
32. Antiinflammatory activity of two phenylindandione derivatives. Rosini S; Trallori L Farmaco Sci; 1976 Jun; 31(6):403-11. PubMed ID: 1278360 [TBL] [Abstract][Full Text] [Related]
33. Long term anticoagulant therapy. A six-year study of 43an indandione derivative. RAWLS WB; CONNOR CA Am J Cardiol; 1959 Oct; 4():470-5. PubMed ID: 14436600 [No Abstract] [Full Text] [Related]
34. [Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione]. Roncato M; Billaud-Mesguich E; Fiessinger JN; Vitoux JF; Aiach M; Alexandre JM Therapie; 1986; 41(3):203-6. PubMed ID: 3750259 [No Abstract] [Full Text] [Related]
35. The effect of two synthetic anticoagulant drugs (coumarin and inandione) in the ewe. Morag M; Smith DR Res Vet Sci; 1971 Mar; 12(2):106-12. PubMed ID: 5572531 [No Abstract] [Full Text] [Related]
36. [Anticoagulant drugs. Fibrinolytic drugs]. Cristea E Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):105-7. PubMed ID: 133400 [No Abstract] [Full Text] [Related]
37. Evaluation of anticoagulant therapy with anisindione (miradon). CONNELL WF; MAYER GA Can Med Assoc J; 1959 May; 80(10):785-90. PubMed ID: 13652026 [No Abstract] [Full Text] [Related]
38. Self-control of long-term oral anticoagulation using a point-of-care device. Roudaut R Arch Cardiovasc Dis; 2008; 101(11-12):683-4. PubMed ID: 19059561 [No Abstract] [Full Text] [Related]
39. [Uricuric action of 2-phenyl-5-bromo-1, 3-indandione at low dosage]. MASINI G; LOMBARDI M Gazz Med Ital; 1960 Aug; 119():330-3. PubMed ID: 13767770 [No Abstract] [Full Text] [Related]
40. [The effects of phenylindanedione on blood coagulation]. CASULA D Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]